SMAD3 and polycystic ovary syndrome: Its upregulation has been linked to lipid-induced stress via the TGFβ-SMAD3 signaling pathway [43], and its dysregulation has been observed in insulin-resistant conditions such as polycystic ovary syndrome and obesity [44,45].